Compared with normal controls, the pre-therapy livers from the CHC patients exhibited more inflammatory infiltration and fibrosis but lower levels of RBP4 expression (68.23±22.56 vs. 95.88 ±12.05%, p = 0.012) (Figure 3). The gene discussed is RBP4; the disease is cryohydrocytosis.